Interleukin 15 (IL15)-based near-infrared photoimmunotherapy
Motofumi Suzuki(Hokkaido University), Hisataka Kobayashi(National Cancer Institute)
Cited by 1
Related Papers
Interleukin-15 after Near-Infrared Photoimmunotherapy (NIR-PIT) Enhances T Cell Response against Syngeneic Mouse Tumors
|Cancers|2020|36
MK-8776, a novel Chk1 inhibitor, exhibits an improved radiosensitizing effect compared to UCN-01 by exacerbating radiation-induced aberrant mitosis
|Translational Oncology|2017|35
Tissue factor targeted near-infrared photoimmunotherapy: a versatile therapeutic approach for malignancies
|Cancer Immunology Immunotherapy|2025|6